475149-33-8

Basic information

• Product Name: 1-cyclobutyl-4-[(4-ethylphenyl)methyl]-5-trifluoromethyl-3-O-t-butyldimethylsilyl-1H-pyrazole
• Synonyms: 1-cyclobutyl-4-[(4-ethylphenyl)methyl]-5-trifluoromethyl-3-O-t-butyldimethylsilyl-1H-pyrazole
• CAS NO: 475149-33-8
• Molecular Weight: 438.609
• Mol File: 475149-33-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1-cyclobutyl-4-[(4-ethylphenyl)methyl]-5-trifluoromethyl-3-O-t-butyldimethylsilyl-1H-pyrazole(CAS DataBase Reference)
• NIST Chemistry Reference: 1-cyclobutyl-4-[(4-ethylphenyl)methyl]-5-trifluoromethyl-3-O-t-butyldimethylsilyl-1H-pyrazole(475149-33-8)
• EPA Substance Registry System: 1-cyclobutyl-4-[(4-ethylphenyl)methyl]-5-trifluoromethyl-3-O-t-butyldimethylsilyl-1H-pyrazole(475149-33-8)

Safety Data

• Hazardous Substances Data: 475149-33-8(Hazardous Substances Data)

Upstream product

• 421592-49-6 3-t-butyldimethylsilyloxy-4-((4-ethylphenyl)methyl)-5-(trifluoromethyl)-1H-pyrazole 
• 2919-23-5 cyclobutanol 

Downstream Products

• 776317-25-0 1-cyclobutyl-4-[(4-ethylphenyl)methyl]-3-hydroxy-5-trifluoromethyl-1H-pyrazole 

Relevant articles and documents

PREVENTIVE/REMEDY FOR DIABETES

The invention provides a prophylactic and therapeutic agent of diabetes mellitus, including a combination of an inhibitor of renal glucose reabsorption and a hypoglycemic agent. In accordance with the invention, hyperglycemia after meals, between meals and during fasting can be ameliorated. More specifically, in accordance with the invention, a therapeutic effect of diabetes mellitus as never been obtained by the hypoglycemic agents of the related art can be achieved.